Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Uranerz Energy Starts On-Site Construction at Nichols Ranch ISR Uranium Mine

Boom Time for Freeport McMoRan Copper & Gold

Centrex Metals Gets Nod for Eyre Peninsula Iron Ore Mine

Macarthur Coal Knocks Back $5.2 Billion Bid from Peabody and ArcelorMittal

Kulczyk Oil Ventures Completes Gas Testing at Olgovskoye-9 Well in Ukraine

Cullen Resources Discovers High-Grade Zinc at TL Property

Beach Energy Discovers Two New Oil Fields at Western Flank

Alarm Over China's Rare Earth Policy, World Looks for New Sources

Bolivia and South Korea Ink Lithium Deal

ABM Resources Intersects 1.67 Million Ounce Deposit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.